Reports for MINT PHARMACEUTICALS INC
Company Name
MINT PHARMACEUTICALS INC
Totals |
||
Shortage reports |
132 |
|
Actual shortage: | 30 (23%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 0 (0%) | |
Resolved: | 102 (77%) | |
Discontinuation Reports |
29 |
|
To be discontinued: | 0 (0%) | |
Discontinued: | 29 (100%) | |
Reversed: | 0 (0%) | |
Late reports |
33 (20%) |
|
Overdue reports |
15 (50%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MINT-CITALOPRAM | 40MG | TABLET | Actual shortage | 2020-07-28 | 2023-01-03 | 121279 |
MINT-CLOPIDOGREL | 75MG | TABLET | Actual shortage | 2018-03-09 | 2018-03-10 | 42370 |
MINT-CLOPIDOGREL | 75MG | TABLET | Actual shortage | 2018-04-06 | 2018-04-07 | 45117 |
MINT-DICLOFENAC | 0.1% | SOLUTION | Actual shortage | 2023-03-27 | 2023-09-27 | 188042 |
MINT-DICLOFENAC | 0.1% | SOLUTION | Actual shortage | 2023-03-27 | 2023-09-27 | 188045 |
MINT-DORZOLAMIDE/TIMOLOL | 5MG 20MG | SOLUTION | Resolved | 2018-01-11 | 2018-09-19 | 35753 |
MINT-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2018-04-12 | 2018-05-08 | 45536 |
MINT-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2023-07-24 | 2024-01-09 | 199939 |
MINT-DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | Resolved | 2018-04-12 | 2018-05-08 | 45539 |
MINT-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2018-01-04 | 2018-02-23 | 34914 |
MINT-ESCITALOPRAM | 10MG | TABLET | Resolved | 2019-12-09 | 2020-06-09 | 100582 |
MINT-ESCITALOPRAM | 20MG | TABLET | Resolved | 2019-12-09 | 2020-06-09 | 100585 |
MINT-EZETIMIBE | 10MG | TABLET | Resolved | 2017-10-26 | 2017-11-11 | 27176 |
MINT-FENOFIBRATE E | 145MG | TABLET | Actual shortage | 2019-04-08 | 2020-04-25 | 80782 |
MINT-FLUOXETINE | 10MG | CAPSULE | Resolved | 2018-07-31 | 2021-01-11 | 57064 |
MINT-FLUOXETINE | 20MG | CAPSULE | Resolved | 2018-07-31 | 2021-01-11 | 57069 |
MINT-GLICLAZIDE MR | 30MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-03-19 | 2024-03-19 | 222750 |
MINT-GLICLAZIDE MR | 60MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2020-03-09 | 2020-03-10 | 108289 |
MINT-HYDRALAZINE | 10MG | TABLET | Resolved | 2019-02-28 | 2019-09-03 | 77148 |
MINT-IRBESARTAN | 75MG | TABLET | Resolved | 2019-01-03 | 2021-07-12 | 71063 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MINT-RIZATRIPTAN ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13544 |
MINT-RIZATRIPTAN ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13553 |
MINT-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95897 |
MINT-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95900 |
MINT-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95903 |
MINT-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95907 |
MINT-SOLIFENACIN | 5MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95913 |
MINT-SOLIFENACIN | 10MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95916 |
MINT-ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13540 |